The article reports on a study which examines the potential of ingenol-B (Ing-B), a semi-synthetic protein kinase C (PKC) activator, for the reactivation of latent HIV. Findings reveal the dual role of Ing-B on HIV replication and its lesser cytotoxicity compared to other diterpenes. It concludes the effectiveness of the compound in reactivating HIV.